PackTalk is a blog for the Healthcare Packaging Industry

Oliver Healthcare Packaging acquires Kansas City Design, forms new premium design business serving the Pharmaceutical and Biologics Market


Published on August 25, 2020

Trevose, Pennsylvania, USA – August 25, 2020 – Oliver Design LLC, a new business unit of Oliver Healthcare Packaging Company, a leading provider of global healthcare packaging, today announced the acquisition of Kansas City Design (KCD). KCD is a premier product and packaging design firm, having served customers in the life sciences industry since 2004 from their design center in Lambertville, New Jersey. KCD has deep expertise in the design and development of complex packaging systems for pharmaceutical and biopharmaceutical therapies. Some of these therapies include cold form foil, blister packaging, prefilled syringes, autoinjectors, transdermal and microneedle patches, wearable devices, and other biomedical therapeutic applications.

 “We are proud to introduce Oliver Design, previously Kansas City Design, to the industry,” said Michael Benevento, President & CEO of Oliver Healthcare Packaging Company. “Over the last 15 years, KCD has earned a reputation for their talented design team and creative approach to difficult packaging challenges. Through this acquisition, Oliver will offer investment and scalability to KCD, making their innovative solutions available to more customers in the biopharma industry as they develop critical patient therapies.”

Mark Foster, packaging industry veteran and the new General Manager for Oliver Design, added “KCD has become a preeminent product and packaging design firm. Their expertise in pharmaceutical and biopharmaceutical therapy applications has resulted in cutting-edge packaging solutions, which has radically improved patient wellness. Along with an experienced team and a passion to serve this market, KCD has a comprehensive array of prototyping and low volume production capabilities. I know I speak for the full team when I say that we are thrilled to work together as Oliver Design.”

William Arnold, founder of KCD, will remain at Oliver Design as the Creative Director. “We are proud of our success at KCD and all the work the team has done to support the industry and our customers,” said William Arnold. “Oliver Design presents tremendous opportunities for customers and this will be an exciting venture as we combine our design expertise with the breadth and depth of Oliver Design.”

Oliver Design will continue technical design and production capabilities, developing long-term plans that are focused on expanding their service offerings to both current and future customers.

ABOUT OLIVER DESIGN LLC

Oliver Design LLC, a business unit of Oliver Healthcare Packaging Company, is a premium design firm focused on biopharmaceutical and biomedical device applications. Combined with a comprehensive set of prototype, quick-turn, and short-run production capabilities, Oliver Design will enable speed to market for companies on the forefront of bringing life-changing therapies to patients. More information about Oliver Design is available at www.oliverdesign.com.

 ABOUT OLIVER HEALTHCARE PACKAGING COMPANY

Oliver Healthcare Packaging Company is a leading supplier of sterile barrier packaging solutions. Oliver offers sterile-grade die-cut lid, roll stock, HDPE card, and pouch products to the medical device and pharmaceutical markets. Headquartered in Grand Rapids, MI, Oliver has manufacturing operations in Feasterville, PA; New Britain, PA; Hamilton, OH; Anaheim, CA; Venray, Netherlands; and Suzhou, China; and has sales offices and technical centers throughout the United States, Europe, China and Singapore. More information about Oliver is available at www.oliverhcp.com.

Full Press Release


Comments (0)

Related Articles

MedTech Conference Hot Topics

November 14, 2020

AdvaMed’s conference takes on medtech’s need to actively increase diversity and inclusion and fight racism, now.

If there is one thing we’ve learned in 2020, it is that our industry, along with others, must take a stand against racial injustice. AdvaMed’s...

Learn More

MD&DI Interviews FDA Commissioner

November 14, 2020

How the FDA continues to generate the science and data of a pandemic, keep the public health on active duty, and serve innovation, in the year that upended the world.

On April 1st, 2020, we published a blog post on the Herculean effort taking place between...

Learn More

How to Assess a Failure Observed Post-Transit

November 14, 2020

Transit failures happen. In fact, one in three transit or distribution studies that come through our lab fail. Sometimes intentionally to test the limits of a package, other times it can be unexpected and bring a project to a halt. When we know what caused...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.